CompletedACTRN12616000824460
Official study titleA Single-Center, Randomized, Open-Label, Two-Period, Cross Over, Pharmacokinetic Study to Assess the Relative Bioavailability of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS1) versus NicoDerm (Registered Trademark) CQ (Registered Trademark) Patch in Smokers
This study has finished and is no longer accepting participants.
In MelbourneAddictionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Chrono Therapeutics Australia PTY LTD
CompletedEUCTR 2008-000227-25
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyADHDHistorical research record
- Countries
- Germany
- Sponsor
- Dept. Child & Adolescent Psychiatrie
CompletedNCT05826392
This study has finished and is no longer accepting participants.
In HoustonDepression, AnxietyInterventional studyAges 13–24
- Countries
- United States
- Sponsor
- Baylor College of Medicine
CompletedNCT05841680
Official study titleA Single-Session Intervention for Families on Waitlists for Child Anxiety
This study has finished and is no longer accepting participants.
In Coral GablesAnxietyBehavioural studyAges 7–17
- Countries
- United States
- Sponsor
- Florida International University
CompletedNCT04988464
What is this study about?This study assessed sleep quality.
This study has finished and is no longer accepting participants.
In AuburnSuicidalityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Auburn University
CompletedNCT06303648
This study has finished and is no longer accepting participants.
In AdelaidePTSDMedication studyAges 25–55
- Countries
- Australia
- Sponsor
- Transcend Therapeutics
CompletedNCT01114308
Official study titleA Randomized, Placebo and Active-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesAddictionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Titan Pharmaceuticals
CompletedNCT00282464
About this title
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
Read the official source — NCT00282464Official study titleA Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarity, DepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT00141271
About this title
A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
Read the official source — NCT00141271Official study titleA Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT00567710
Official study titleA Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study to Determine the Efficacy, Tolerability and Safety of Low and High Non-overlapping Dose Ranges of BL-1020 Compared to Placebo and Risperidone
This study has finished and is no longer accepting participants.
In IrvingSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- BioLineRx, Ltd.
CompletedEUCTR 2006-003475-13
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
- Countries
- Germany, Greece
- Sponsor
- Pfizer Pharma GmbH
CompletedNCT04969146
This study has finished and is no longer accepting participants.
In PittsburghDepressionBehavioural studyAges 21+
- Countries
- United States
- Sponsor
- University of Pittsburgh
